What CBCC Global Research does

CBCC Global Research is a privately held, full-service Clinical Research Organization (CRO) founded in 1994 and dual-headquartered in Bakersfield, California (USA) and Ahmedabad, Gujarat (India). The company provides end-to-end clinical development services across Phase I-IV trials, including site feasibility and monitoring, regulatory submissions, data management, bio-statistics, medical writing, pharmacovigilance, and ISO 9001:2015-certified core lab imaging services (ECHO, OCT, CT, MRI, PET, IVUS, etc.). It operates across five core therapeutic verticals — oncology, ophthalmology, neuro-psychiatry, rare disease, and dermatology — and is differentiated by a rescue-trial practice that has reportedly completed startup activities in under three months for over 90% of rescue studies and exceeded patient recruitment targets in over 80% of such cases.

The company's underlying technology stack is composed rather than proprietary: CBCC works across 9+ Electronic Data Capture (EDC) platforms, maintains a global library of 250+ standard Case Report Forms (CRFs), and applies risk-based monitoring with integrated quality checks. Its technology differentiators are concentrated in operational scale (275+ professionals, ~50% with 10+ years of clinical trial experience, 500+ trial sites in database, 250+ trials executed) and a regulatory track record (9+ USFDA inspections including multiple with ZERO 483 observations, 40+ ANDA, 15+ MAA, 18+ 505(b)(2) NDA submissions, 25+ scientific advisory meetings with USFDA/EMA/CDSCO).

CBCC operates a B2B enterprise go-to-market: clients — primarily pharmaceutical, bio-pharmaceutical, medical device, and diagnostics companies in the US, EU, China, South Korea, and India — engage via an RFP process or direct outreach. All engagements are custom-priced project-based professional services contracts, typically spanning multiple years, with no public pricing. Lead generation is hybrid: enterprise field sales supported by heavy conference participation (CPHI, BIO, ASCO, AACR, DCAT, J.P. Morgan Healthcare). In January 2026 the company rebranded to REV Clinical (standing for Reliability, Excellence, Velocity), signaling a positioning refresh while retaining the operational CBCC identity.

Name

CBCC Global Research

Legal name

CBCC Global Research India

Website

https://cbcc.global

Company type

Private

Founded year

1994

Operating status

Operating

Short description

CBCC Global Research is a privately held, full-service Clinical Research Organization (CRO) founded in 1994, dual-headquartered in the USA and India, providing Phase I-IV clinical trial management, regulatory, data management, medical writing, and core lab services across oncology, ophthalmology, neuro-psychiatry, rare disease, and dermatology to global pharma and biotech sponsors.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Scientific Research and Development Services (5417), Medical Laboratories (621511)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical Research Organization
• Phase I-IV Clinical Trials
• Medical Writing Services
• Biometric Core Lab
• Regulatory Submissions

Headquarters

HQ city

Bakersfield

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Phase I-IV Clinical Trial Services: Full-service clinical trial management including site feasibility, site contracting, site initiation, monitoring, central/virtual/risk-based monitoring, data management, bio-statistics, medical writing, regulatory submissions, pharmacovigilance, and medical monitoring.
2. Medical and Scientific Writing Services: Regulatory and scientific medical writing including protocol development, CSR, manuscripts, review articles, abstracts, posters, CER writing, and market access/HEOR writing services.
3. 505(b)(2) Clinical Development Programs: Regulatory pathway consulting and clinical development program execution for 505(b)(2) submissions including Pre-IND, IND, NDA, and ANDA preparation and support.
4. Core Lab Services: ISO 9001:2015 certified central laboratory providing medical imaging and cardiovascular analysis services across multiple modalities.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

CBCC Global Research is a full-service Clinical Research Organization (CRO) providing end-to-end Phase I-IV clinical trial management for pharmaceutical, bio-pharmaceutical, medical device, and diagnostics companies. Core offerings span site feasibility, monitoring, data management, bio-statistics, regulatory submissions, medical writing, pharmacovigilance, and ISO 9001:2015 certified core lab imaging services. The company specializes in Oncology, Ophthalmology, Neuro-Psychiatry, Rare Disease, and Dermatology, and runs dedicated 505(b)(2) clinical development programs and rescue trial operations.

Product overview

CBCC Global Research is a full-service Clinical Research Organization (CRO) providing end-to-end pharmaceutical clinical development services. The company operates a unified service model centered around Phase I-IV Clinical Trial Management as its core offering, supplemented by specialized Writing Services, 505(b)(2) Clinical Development Programs, and Core Lab Services. The company has recently rebranded to REV Clinical (January 2026). Services span five therapeutic areas: Oncology, Ophthalmology, Neuro-Psychiatry, Rare Disease, and Dermatology. Additional specialized offerings include Rescue Trials for struggling studies. The company maintains presence in the USA and India with operations supported by a team of over 275 professionals across 400+ trial sites.

Differentiator

Problem solved

Functional benefit

Products and services

• Phase I-IV Clinical Trial Services Comprehensive clinical trial management services spanning Phase I through Phase IV, including site feasibility, site contracting, site initiation, central/virtual/risk-based monitoring, data management, bio-statistics, medical writing, regulatory submissions, pharmacovigilance, and medical monitoring for pharmaceutical, bio-pharmaceutical, medical device, and diagnostics companies.
• Writing Services Scientific and regulatory medical writing services including protocol development, investigator brochures, informed consent forms, clinical study reports (CSR), manuscripts, review articles, abstracts, posters, CER writing, and market access/HEOR writing for regulatory submissions and scientific publication.
• 505(b)(2) Clinical Development Programs Regulatory pathway consulting and clinical development program execution for 505(b)(2) drug submissions, including product concept evaluation, regulatory strategy, pre-IND consultations, IND, NDA, and ANDA preparation and support, including orphan drug designation advisory.
• Core Lab Services ISO 9001:2015 certified medical imaging central laboratory providing independent analysis across ECHO, spirometry, angiography, OCT, ECG, CT, MRI, SPECT, PET, DEXA, X-ray, CT-Angio, and IVUS modalities for clinical trial sponsors requiring cardiac safety and imaging endpoint data.
• Oncology Clinical Trials Specialized oncology clinical trial services covering solid tumors and hematological malignancies including breast, colorectal, prostate, ovarian, renal, pancreatic, and lung cancers as well as AML and MDS, with experience in 25+ early phase studies on complex injectable and solid oral formulations across 150+ sites and 10+ 505(b)(2) oncology programs ranging from early phase to complex Phase III trials.
• Ophthalmology Clinical Trials Specialized ophthalmology clinical trial services covering cataract, glaucoma, dry eye disease, AMD, astigmatism, vitrectomy, and clinical endpoint studies, supported by an exclusive site network across 70+ sites in the US and India for drug supply management, blinding IP management, and multi-site distribution.
• Neuro-Psychiatry Clinical Trials Specialized neuro-psychiatry clinical trial services covering schizophrenia, bipolar I disorder, Parkinson's disease, seizures, myasthenia gravis, schizoaffective disorder, and long-acting injectables, with direct access to a dedicated PSYCH unit in California and support for complex psychiatric assessments and long-term patient follow-up.
• Rare Disease Clinical Trials Rare disease clinical trial services across hepatobiliary diseases (PSC, PBC, NASH), ophthalmology rare diseases (Sjogren's syndrome, retinoblastoma), and oncology rare diseases (glioblastoma, renal cell carcinoma), with regulatory expertise in FDA, EMA, and CDSCO orphan drug and rare disease pathways.
• Dermatology Clinical Trials Specialized dermatology clinical trial services covering acne vulgaris, psoriasis, atopic dermatitis, actinic keratosis, hand and foot syndrome, and pruritus, supported by an extensive site network in the US and India and expertise in blinding IP management and dermatological assessments.
• Rescue Trials Specialized rescue clinical trial management services for trials stuck at critical junctures, with a documented track record of exceeding patient recruitment targets for more than 80% of rescue trials and completing startup activities for more than 90% of rescue trials in under 3 months.

Quantifiable outcome

• 90%+ patient retention rate across all therapeutic areas
• +5 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered minor and core.

• iNGENū CROminorStrategic or Co-development Partner · 13 February 2025CBCC signed an MoU with iNGENū CRO, an Australia-based CRO. The partnership extends CBCC's geographic footprint in the Asia-Pacific region through collaboration with an Australian CRO partner.
• StepWise MedicalcoreStrategic or Co-development Partner · 23 July 2021CBCC Global Research and StepWise Medical entered into a joint global collaboration providing a framework for cooperation in clinical research. CBCC gains access to StepWise Medical's AI-driven, biomarker-based software for detecting, diagnosing, and predicting progression of ophthalmic conditions. StepWise Medical benefits from CBCC's integrated full-service global clinical operations for its portfolio companies. The partnership aligns with CBCC's strategy of expanding its digital services for clients and sponsors.
• N Power MedicineminorStrategic or Co-development PartnerMichael V. Seiden M.D., Ph.D., Chief Medical Officer at N Power Medicine, serves on CBCC's Board of Directors. N Power Medicine is an innovative platform company that empowers community oncology practices to strengthen their culture of research, aligning with CBCC's oncology focus.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Parexel International: Large global CRO offering Phase I-IV clinical development, regulatory, and post-marketing services. Comparable full-service clinical offering and therapeutic breadth to CBCC but at much larger scale and broader geographic presence, including proprietary technology and DCT capabilities.
• Syneos Health: Large global biopharmaceutical solutions organization offering clinical development and commercialization services. Comparable service portfolio to CBCC across Phase I-IV, biometrics, and regulatory consulting but at enterprise scale with significantly larger headcount and global footprint.
• Worldwide Clinical Trials: Mid-to-large global CRO with strong specialty therapeutic focus including neuroscience, oncology, and rare disease. Comparable to CBCC in therapeutic-area emphasis but operates at significantly greater scale across more geographies.
• ICON plc: Global full-service CRO with Phase I-IV capabilities, central lab services, and embedded technology. Overlaps with CBCC's full-service clinical, core lab, and biometrics offerings but at vastly greater scale, geographic reach, and with proprietary technology platforms.

Direct peers

• GVK Biosciences: India-headquartered CRO with deep BA/BE and clinical development capabilities, recently merged with Aragen. Multiple CBCC senior leaders (CEO Manoj Vyas, BD Director Jaimeen Vanparia, Clinical Ops Head Harakh Shah) previously held senior roles at GVK, indicating directly comparable service lines and customer base.
• SIRO Clinpharm: India-based full-service CRO offering clinical operations, data management, biostatistics, and pharmacovigilance. Comparable to CBCC in therapeutic breadth, India-led delivery model, and target sponsor segments across pharma and biotech.
• Veeda Clinical Research: India-headquartered full-service CRO offering Phase I-IV clinical trials, bioequivalence studies, and bioanalytical services. Directly comparable to CBCC in geographic footprint, India delivery model, therapeutic-area breadth, and target customer segments in pharma and generics.
• Ora (Ophthalmic Research Associates): Specialty CRO focused exclusively on ophthalmology clinical research. CBCC's Global Head of Ophthalmology (Sanjeev Ganatra) previously served on Ora's commercial team, reflecting direct therapeutic-area and competitive overlap in ophthalmology trials.
• Novum Pharmaceutical Research Services: US-based CRO with strong dermatology and early-phase clinical trial expertise. CBCC's Head of BD (Nikhil Gandhi) was previously Director of BD at Novum for 16 years, indicating close operational and customer-overlap comparability.
• iNGENū CRO: Australia-based specialty CRO with Phase I-IV capabilities, particularly in early-phase and oncology. Recently signed an MoU with CBCC to extend Asia-Pacific reach, indicating directly comparable service offerings and target customer base in pharma/biotech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/CBCC_CRO
• YouTubeyoutube.com/channel/UCw-uVfBa-TOH6Jz143ahXrQ
• LinkedInlinkedin.com/company/cbcc-global-research

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CBCC Global Research